The Rheumatologist
COVID-19 NewsACR Convergence
You are here: Home / Articles / Study Associates Higher Risks with Total Joint Arthroplasty among Patients with Hepatitis C

Study Associates Higher Risks with Total Joint Arthroplasty among Patients with Hepatitis C

• By Catherine Kolonko

Catherine Kolonko is a medical writer based in Oregon.

References

  1. Issa K, Boylan MR, Naziri Q, et al. The impact of hepatitis C on short-term outcomes of total joint arthroplasty. J Bone Joint Surg Am. 2015 Dec 2;97(23):1952–1957.
  2. Javidan P, Walker RH. Take care with type C: Serious considerations in the selection of patients with hepatitis C for total joint arthroplasty: Commentary on an article by Kimona Issa, MD, et al.: ‘The Impact of Hepatitis C on Short-Term Outcomes of Total Joint Arthroplasty.’ J Bone Joint Surg Am. 2015 Dec 2;97(23):e77.

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »